Obesity, heart failure with preserved ejection fraction, and the role of glucagon‐like peptide‐1 receptor agonists

Obesity, heart failure with preserved ejection fraction, and the role of glucagon‐like peptide‐1 receptor agonists

Abstract Heart failure with preserved ejection fraction (HFpEF) has a high prevalence, affecting more than 50% of patients with heart failure. HFpEF is associated with multiple comorbidities, and obesity is one of the most common. A distinct phenotype has been proposed for obese patients with HFpEF....

Full description

Bibliographic Details
Main Authors: Giuliana Cimino, Muthiah Vaduganathan, Carlo M. Lombardi, Matteo Pagnesi, Enrico Vizzardi, Daniela Tomasoni, Marianna Adamo, Marco Metra, Riccardo M. Inciardi
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:ESC Heart Failure
Subjects:
Heart failure with preserved ejection fraction
Glucagon‐like peptide‐1 receptor agonists
Obesity
Online Access:https://doi.org/10.1002/ehf2.14560

Similar Items

Similar Items